AAP
BIOA

Arax Advisory Partners’s BioAge Labs BIOA Stock Holding History

Arax Advisory Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
+542
New +$9.79K ﹤0.01% 4202
2026
Q1 		– Sell
-4
Closed -$53 – 4416
2025
Q4 		$53 Sell
4
-470
-99% -$4.17K ﹤0.01% 3910
2025
Q3 		$2.79K Buy
+474
New +$2.22K ﹤0.01% 3028

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Arax Advisory Partners's BIOA Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in BioAge Labs (BIOA) in Q2 2026: 542 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #4202 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in BIOA as recently as Q4 2025.

Arax Advisory Partners first reported a position in BIOA in Q3 2025 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Arax Advisory Partners held 542 shares of BioAge Labs worth $13.3K as of Q2 2026.
  • BioAge Labs was a new Arax Advisory Partners position in Q2 2026.
  • BioAge Labs made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4202 holding.
  • Arax Advisory Partners first reported a position in BioAge Labs in Q3 2025 and has held it in 3 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.